The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit
- PMID: 1692300
- PMCID: PMC1385618
The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit
Abstract
The specific recognition of the acetylcholine receptor and its alpha-subunit by T cells derived from patients with myasthenia gravis or mice with experimental autoimmune myasthenia gravis raises the question of the role of autoreactive T cells in the myasthenic process. Sequences of the acetylcholine receptor alpha-subunit previously shown to be immunogenic in myasthenic patients were tested for their immunogenicity in various inbred mouse strains. High, intermediate and low T-cell proliferative responses could be observed to peptides representing sequences 195-212 and 259-271 of the human acetylcholine receptor alpha-subunit. Following immunization with the Torpedo acetylcholine receptor, lymphocytes of SJL mice proliferated efficiently to p 195-212 but not to p259-271. On the other hand, lymph node cells of BALB/c mice responded well to p259-271 but not to p195-212. Thus, the influence of the genetic make-up of the examined mice on the immune response to the two peptides could be clearly demonstrated by the existence of strain-dependent immunodominant and cryptic regions on the autoantigen. The differences between the strains were less pronounced when antibody responses were measured to these two T-cell epitopes, although a partial correlation with the proliferative responses could be observed. It can be concluded that epitopes specifically recognized by T lymphocytes of patients with myasthenia gravis also represent specific T-cell epitopes in the autoreactivity to the acetylcholine receptor in mice and that immune responsiveness to these peptides is influenced by the genetic make-up of the responding mouse strains.
Similar articles
-
Fine specificity of T cell lines and clones that are capable of inducing autoimmune manifestations in mice.Cell Immunol. 1994 Aug;157(1):11-28. doi: 10.1006/cimm.1994.1201. Cell Immunol. 1994. PMID: 7518748
-
T cell receptor expression and differential proliferative responses by T cells specific to a myasthenogenic peptide.Cell Immunol. 1997 Aug 25;180(1):20-8. doi: 10.1006/cimm.1997.1171. Cell Immunol. 1997. PMID: 9316635
-
T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit.Ann Neurol. 1992 Mar;31(3):311-8. doi: 10.1002/ana.410310314. Ann Neurol. 1992. PMID: 1379027
-
Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides.Crit Rev Immunol. 1997;17(5-6):481-95. Crit Rev Immunol. 1997. PMID: 9419435 Review.
-
On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.Crit Rev Immunol. 2001;21(1-3):1-27. Crit Rev Immunol. 2001. PMID: 11642597 Review.
Cited by
-
Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease.J Mol Med (Berl). 2005 Jan;83(1):12-25. doi: 10.1007/s00109-004-0615-3. Epub 2004 Dec 11. J Mol Med (Berl). 2005. PMID: 15592920 Review.
-
Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis.Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2028-33. doi: 10.1073/pnas.0409549102. Epub 2005 Jan 26. Proc Natl Acad Sci U S A. 2005. PMID: 15677327 Free PMC article.
-
A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis.Immunology. 2006 Jul;118(3):413-24. doi: 10.1111/j.1365-2567.2006.02398.x. Immunology. 2006. PMID: 16827902 Free PMC article.
-
Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice.Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2168-73. doi: 10.1073/pnas.040554597. Proc Natl Acad Sci U S A. 2000. PMID: 10681457 Free PMC article.
-
Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cells.Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10285-90. doi: 10.1073/pnas.0504578102. Epub 2005 Jul 12. Proc Natl Acad Sci U S A. 2005. PMID: 16014414 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources